MiBolsilloColombia on MSN
Roche, AstraZeneca and Johnson & Johnson plan major US drug manufacturing push
Major drugmakers Roche, AstraZeneca, and Johnson & Johnson plan to invest billions to expand drug manufacturing in the United States.
Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard ...
Astrazeneca has laid out plans aimed at “upgrading” its US listing in the latest blow to the London Stock Exchange. The Cambridge-based pharma giant said it would replace its existing Nasdaq listing ...
FILE PHOTO: A pedestrian crosses a road near AstraZeneca Plc's factory in Macclesfield, U.K., on Thursday, July 4, 2013. Pfizer Inc. proposed buying AstraZeneca Plc for about 58.8 billion pounds ...
(Reuters) -AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This ...
AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their ...
Add Yahoo as a preferred source to see more of our stories on Google. A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement ...
AstraZeneca makes proposals to cut U.S. drug price cuts CEO Soriot says also considering direct sales to customers AstraZeneca maintains annual outlook Second-quarter sales and profit beat analysts' ...
US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date AstraZeneca has proudly awarded $3.4 million to nonprofit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results